肺胀中医治未病实践指南的制定  

Practice Guideline Formulation for Traditional Chinese Medicine Preventive Treatment of Lung Distension

作　　者：于雪峰[1] 李国信[1] 李丁蕾[1] 姚明[1] 丁晓欢[1] 

机构地区：[1]辽宁中医药大学附属第二医院肺病科,沈阳110034

出　　处：《世界科学技术-中医药现代化》2017年第5期740-743,共4页Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology

基　　金：国家中医药管理局中医药标准化项目(SATCM-2015-BZ[289]):中医治未病实践指南-肺胀瘥后防复;负责人:于雪峰;科学技术部国家"十二五"重大新药创制科技重大专项(2012ZX09303-017):中药新药临床评价研究技术平台;负责人:李国信

摘　　要：中医肺胀相当于现代医学的慢性阻塞性肺疾病,近年来患病率和病死率逐年升高。本文以国家中医药管理局中医药标准化项目-中医治未病实践指南-肺胀瘥后防复为依托,以"治未病"理论为基础,依据古代及现代文献证据,通过德尔菲法专家问卷调查、专家共识会议,形成《中医治未病实践指南肺胀瘥后防复》初稿,进行同行意见征求,为进一步完善指南奠定基础。以期通过该指南达成行业共识,提高稳定期患者生活质量,减轻患者经济负担,提升中医"治未病"的理论内涵和实践价值。Lung distension belongs to chronic obstructive pulmonary disease（COPD） in modern medicine. In recent years, its disease incidence and mortality have increased year by year. Supported by the traditional Chinese medicine（TCM） standardization of the State Administration of TCM project-TCM preventive treatment practice guidelines-prevention of lung distension recrudescence, the first draft of the TCM Preventive Treatment Practice Guideline on Prevention of Lung Distension Recrudescence was formulated on the basis of＂preventive treatment＂theory, evidences from both ancient and modern literatures, and through the Delphi method as well as expert consensus conference. And then,peer review comments were collected, which laid the foundation for the further improvement of this guideline. This guideline was aimed to achieve the industry consensus, to improve the quality of life（Qo L） in patients of the stable period, to reduce the economic burden of patients, as well as to improve both the theoretical connotation and practical value of＂preventive treatment＂in TCM.

关 键 词：肺胀 慢性阻塞性肺疾病 治未病 实践指南 

分 类 号：R256.14[医药卫生—中医内科学]